Search results for:
blinatumomab
blinatumomab
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Blinatumomab |
POWDER FOR INJECTION, INTRAVENOUS |
35 mcg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Dec. 5, 2024
UNC Health
Caution – Category 2: Non-antineoplastic Hazardous Medication, see below for exposure mitigation strategies
Med Center
UNC Medical Center Formulary Restrictions